跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salbuseth - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salbuseth
Approved
STANDARD
Salbuseth
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
142c3493f3576823
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
142c3493f3576823
Drug Approval Philippines Name
Salbuseth
Product Name
Salbuseth
Registration Number
DRP-3802-01
Brand Name
Salbuseth
Generic Name
Salbutamol (as sulfatre)
Dosage Form
Tablet
Dosage Strength
2 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
25 May 2025
Expiry Date
25 May 2031
Pharmacologic Category
Selective beta-2-adrenoreceptor agonist
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
142c3493f3576823
Type
Standard
Back to Philippines FDA Approvals